Detalhe da pesquisa
1.
A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice.
Front Pharmacol
; 14: 1204905, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37332345